GS-0272 100 mg/mL solution for intravenous infusion or subcutaneous injection (formerly known as GS-0272) clinical trials

A 2-part study to investigate the safety, tolerability and effect of MB272 in healthy volunteers

This study, called MB272, looked at a new drug (GS-0272) in healthy volunteers. It checked if the drug was safe, how well people tolerated it, and how it acted in the body when given in different ways and doses. The goal was to gather early information about this potential new medicine.